MedCap AB (publ) (STO:MCAP)
Sweden · Delayed Price · Currency is SEK 551.00
+5.00 (0.92%)
Aug 14, 2026, 5:29 PM CET
MedCap AB Ratios and Metrics
Market cap in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8,252 | 8,278 | 8,899 | 4,997 | 3,206 | 2,636 | |
Market Cap Growth | -17.40% | -6.98% | 78.07% | 55.89% | 21.63% | -22.55% |
Enterprise Value | 8,425 | 8,431 | 8,964 | 5,100 | 3,260 | 2,772 |
Last Close Price | 551.00 | 549.00 | 601.00 | 337.50 | 216.50 | 178.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 34.30 | 37.66 | 42.91 | 29.02 | 27.26 | 27.31 |
Forward PE | 24.92 | 31.55 | 39.28 | 25.95 | 25.95 | 25.95 |
PS Ratio | 3.66 | 3.92 | 4.92 | 3.15 | 2.85 | 2.85 |
PB Ratio | 5.20 | 5.67 | 6.91 | 4.87 | 3.73 | 3.78 |
P/TBV Ratio | 38.56 | 24.78 | 13.14 | 11.86 | 6.98 | 8.95 |
P/FCF Ratio | 22.71 | 26.11 | 27.97 | 24.27 | 54.15 | 37.12 |
P/OCF Ratio | 21.31 | 24.15 | 24.72 | 21.92 | 37.49 | 22.66 |
PEG Ratio | - | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.73 | 4.00 | 4.96 | 3.21 | 2.90 | 2.99 |
EV/EBITDA Ratio | 17.81 | 22.35 | 29.41 | 19.01 | 17.28 | 19.64 |
EV/EBIT Ratio | 26.56 | 29.21 | 37.23 | 23.59 | 21.86 | 26.70 |
EV/FCF Ratio | 23.18 | 26.60 | 28.17 | 24.77 | 55.06 | 39.03 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.29 | 0.33 | 0.28 | 0.25 | 0.40 | 0.37 |
Debt / EBITDA Ratio | 0.97 | 1.15 | 1.05 | 0.85 | 1.56 | 1.52 |
Debt / FCF Ratio | 1.26 | 1.52 | 1.13 | 1.27 | 5.74 | 3.62 |
Net Debt / Equity Ratio | 0.11 | 0.08 | -0.01 | 0.07 | 0.12 | 0.17 |
Net Debt / EBITDA Ratio | 0.40 | 0.30 | -0.04 | 0.27 | 0.55 | 0.83 |
Net Debt / FCF Ratio | 0.47 | 0.36 | -0.04 | 0.36 | 1.75 | 1.65 |
Asset Turnover | 0.93 | 0.92 | 0.99 | 1.03 | 0.87 | 0.82 |
Inventory Turnover | 3.06 | 3.23 | 2.75 | 3.01 | 2.86 | 2.48 |
Quick Ratio | 1.32 | 1.40 | 1.88 | 1.38 | 1.86 | 1.29 |
Current Ratio | 1.86 | 2.01 | 2.77 | 2.23 | 2.46 | 1.96 |
Return on Equity (ROE) | 16.36% | 16.07% | 18.08% | 18.30% | 15.16% | 15.10% |
Return on Assets (ROA) | 8.15% | 7.85% | 8.24% | 8.74% | 7.17% | 5.76% |
Return on Invested Capital (ROIC) | 14.47% | 15.48% | 16.22% | 16.27% | 13.03% | 11.35% |
Return on Capital Employed (ROCE) | 14.20% | 13.70% | 14.50% | 16.40% | 13.20% | 11.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.92% | 2.66% | 2.33% | 3.45% | 3.67% | 3.66% |
FCF Yield | 4.40% | 3.83% | 3.58% | 4.12% | 1.85% | 2.69% |
Buyback Yield / Dilution | -0.47% | -0.94% | -0.05% | -0.33% | -0.04% | -3.10% |